Medicines Australia Appoints Interim CEO
This article was originally published in Scrip
Executive Summary
Australia's pharmaceutical industry association, Medicines Australia, has appointed Lee Hill as its new interim CEO after its former CEO, Tim James, resigned in December. Mr Hill, who will likely stay in the position until June, has more than 10 years' experience as a "senior business leader," says the association. He has held posts such as CEO or managing director at leading pharmaceutical companies and consultancies. During the next six months he will prepare for a smooth transition for his successor and will work with the association's board to identify the organization's needs for ensuring "long-term success".